As the UK government publishes the latest in a succession of guidance documents on how Brexit will affect the supply of medicines – with a particular focus on preparations for a ‘no deal’ Brexit – the British Generic Manufacturers Association’s (BGMA’s) position on Brexit is clear.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?